Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outpatient Pulmonary Rehabilitation in Patients With Advanced Stage Non-small Cell Lung Cancer Receiving Immunotherapy: a Randomized Controlled Trial (OPAL-study)

NCT06436625 is registered in ClinicalTrials.gov with Karl Landsteiner Institute for Lung Research and Pneumological Oncology as lead sponsor.

NCT NCT06436625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06436625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outpatient Pulmonary Rehabilitation in Patients With Advanced Stage Non-small Cell Lung Cancer Receiving Immunotherapy: a Randomized Controlled Trial (OPAL-study)
Lead sponsor
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Phase
Not applicable
Overall status
Recruiting
Start date
January 27, 2025
Completion date
January 31, 2028
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc stage iv